<DOC>
	<DOC>NCT00180791</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of the combination of surgery, conventional chemotherapy, sequential high-dose chemotherapy with peripheral blood stem cell transplantation and reduced dose radiation therapy in high-risk PNET brain tumors.</brief_summary>
	<brief_title>High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors, Primitive</mesh_term>
	<mesh_term>Medulloblastoma</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<criteria>Medulloblastoma in patients less than 5 years of age Brain PNET in patients less than 10 years of age Histologically documented diagnosis Body weight of &gt; 8 kg Parents' refusal</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Brain PNET</keyword>
</DOC>